These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis and evaluation of benzimidazole carbamates bearing indole moieties for antiproliferative and antitubulin activities. Guan Q; Han C; Zuo D; Zhai M; Li Z; Zhang Q; Zhai Y; Jiang X; Bao K; Wu Y; Zhang W Eur J Med Chem; 2014 Nov; 87():306-15. PubMed ID: 25262051 [TBL] [Abstract][Full Text] [Related]
3. Tetrahydroisoquinoline Sulfamates as Potent Microtubule Disruptors: Synthesis, Antiproliferative and Antitubulin Activity of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal Structure. Dohle W; Prota AE; Menchon G; Hamel E; Steinmetz MO; Potter BVL ACS Omega; 2019 Jan; 4(1):755-764. PubMed ID: 30775645 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors. Khelifi I; Naret T; Renko D; Hamze A; Bernadat G; Bignon J; Lenoir C; Dubois J; Brion JD; Provot O; Alami M Eur J Med Chem; 2017 Feb; 127():1025-1034. PubMed ID: 28166995 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamate. Jourdan F; Leese MP; Dohle W; Hamel E; Ferrandis E; Newman SP; Purohit A; Reed MJ; Potter BV J Med Chem; 2010 Apr; 53(7):2942-51. PubMed ID: 20225862 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, antitubulin, and antiproliferative SAR of C3/C1-substituted tetrahydroisoquinolines. Dohle W; Leese MP; Jourdan FL; Major MR; Bai R; Hamel E; Ferrandis E; Kasprzyk PG; Fiore A; Newman SP; Purohit A; Potter BV ChemMedChem; 2014 Feb; 9(2):350-70. PubMed ID: 24436228 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents. Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 1-benzylidene-3,4-dihydronaphthalen-2-one as a new class of microtubule-targeting agents. Liu J; Zheng CH; Ren XH; Zhou F; Li W; Zhu J; Lv JG; Zhou YJ J Med Chem; 2012 Jun; 55(12):5720-33. PubMed ID: 22676247 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site. Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162 [TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents. Leese MP; Jourdan FL; Gaukroger K; Mahon MF; Newman SP; Foster PA; Stengel C; Regis-Lydi S; Ferrandis E; Di Fiore A; De Simone G; Supuran CT; Purohit A; Reed MJ; Potter BV J Med Chem; 2008 Mar; 51(5):1295-308. PubMed ID: 18260615 [TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site. Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors. Wang YT; Qin YJ; Yang N; Zhang YL; Liu CH; Zhu HL Eur J Med Chem; 2015 Jun; 99():125-37. PubMed ID: 26070164 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents. Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492 [TBL] [Abstract][Full Text] [Related]
14. 4,5-Diaryl-3H-1,2-dithiole-3-thiones and related compounds as combretastatin A-4/oltipraz hybrids: Synthesis, molecular modelling and evaluation as antiproliferative agents and inhibitors of tubulin. Wang Z; Qi H; Shen Q; Lu G; Li M; Bao K; Wu Y; Zhang W Eur J Med Chem; 2016 Oct; 122():520-529. PubMed ID: 27428395 [TBL] [Abstract][Full Text] [Related]
15. 4- and 5-aroylindoles as novel classes of potent antitubulin agents. Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents. Ruan BF; Lu X; Li TT; Tang JF; Wei Y; Wang XL; Zheng SL; Yao RS; Zhu HL Bioorg Med Chem; 2012 Jan; 20(2):1113-21. PubMed ID: 22189271 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of thiophene analogues of chalcones. Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents. Galli U; Travelli C; Aprile S; Arrigoni E; Torretta S; Grosa G; Massarotti A; Sorba G; Canonico PL; Genazzani AA; Tron GC J Med Chem; 2015 Feb; 58(3):1345-57. PubMed ID: 25584687 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents. Zhou P; Liang Y; Zhang H; Jiang H; Feng K; Xu P; Wang J; Wang X; Ding K; Luo C; Liu M; Wang Y Eur J Med Chem; 2018 Jan; 144():817-842. PubMed ID: 29306206 [TBL] [Abstract][Full Text] [Related]